GoodRx Care Appears in 50.3% of AI Answers. Here's Our Five-Step Plan to Improve Its AI Visibility.

Mark HuntleyBy Mark HuntleyFounder and CEO
11 minutes read

Key Takeaways

  • GoodRx Care appeared in 50.31% of benchmark answers and was recommended in 34.58%, with no negative mentions recorded.
  • The main gap is reach: the brand is treated well when it appears, but it surfaces less often than Hims and Ro.
  • No conflicting claims were recorded in the captured answers, so the first priority is verification rather than correction.
  • Owned service pages and buyer questions about online ED treatment are the clearest starting points for new briefs.

Answer Capsule

In November 2026, GoodRx Care appeared in 243 of 483 AI answers included in the ED Treatment Pills benchmark (50.31%). It received 167 recommendations (34.58%), with 112 Top 3 placements and 57 first-place recommendations. A mention means the company appeared in an answer; a recommendation means the answer affirmatively endorsed it.

Our plan compares the company with its competitors, checks conflicting AI claims against reliable sources, and identifies website pages, third-party sources and buyer questions to address. This edition establishes a research baseline. It does not claim a change from earlier editions measured on a different basis. Conflicting AI claims require verification before corrections are proposed.

Current AI visibility

Questions This Section Answers

  • How do GoodRx Care mentions, recommendations and placements compare with its ED Treatment Pills peers?

GoodRx Care recorded 243 mentions (50.31%) and 167 recommendations (34.58%) across 483 answers included in the benchmark. Top 3 placements numbered 112; first-place recommendations numbered 57. Framing among its mentions was 181 positive, 62 neutral and 0 negative.

Rank

Company

Mentions

Mention rate

Recommendations

Recommendation rate

Top 3

Top 3 rate

#1

#1 rate

1

Hims

452

93.58%

219

45.34%

170

35.20%

98

20.29%

2

Ro

366

75.78%

201

41.61%

152

31.47%

30

6.21%

3

GoodRx Care

243

50.31%

167

34.58%

112

23.19%

57

11.80%

4

Lemonaid Health

149

30.85%

101

20.91%

35

7.25%

1

0.21%

5

BlueChew

212

43.89%

67

13.87%

37

7.66%

10

2.07%

6

plushcare

88

18.22%

57

11.80%

16

3.31%

5

1.04%

7

Rex MD

84

17.39%

45

9.32%

26

5.38%

1

0.21%

8

K Health

6

1.24%

6

1.24%

1

0.21%

0

0.00%

9

Blink Health

5

1.04%

4

0.83%

1

0.21%

0

0.00%

10

Optum

9

1.86%

2

0.41%

1

0.21%

1

0.21%

GoodRx Care sits third in this benchmark, appearing in roughly half of the answers and carrying a recommendation in about a third. Its positive framing is strong, with no negative mentions recorded. That combination suggests the brand is well received when it surfaces, so the practical question is reach rather than reputation.

Placement is the sharper contrast. GoodRx Care earns first-place recommendations at a higher rate than Ro, even though Ro appears far more often. The gap to the leaders is therefore about how frequently the brand enters the conversation, not how it is treated once there. A visibility comparison against the two leaders would show where that gap concentrates.

Because this edition sets a broader baseline, these figures describe one selected sample rather than a trend. The agency would treat them as a starting reference point and pair them with a fact-check list so priorities rest on verified evidence.

What changed since last month

Questions This Section Answers

  • How did GoodRx Care counts and coverage differ across the available monthly snapshots?

Metric

Nov 2026

Mentions

243 / 483 (50.31%)

Recommendations

167 / 483 (34.58%)

Top 3 recommendations

112 / 483 (23.19%)

#1 recommendations

57 / 483 (11.80%)

Only months with verified results are shown. Monthly sample coverage is listed in Methodology.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

This edition is the first to use the wider question set, so the monthly record shows a single verified sample rather than a movement from earlier editions. The earlier, narrower figures stay in the archive and are not read as a trend. Any apparent change in totals should be treated as a difference in what was measured.

The useful reading is that this month establishes the reference point future editions can be compared against. The agency would keep the question set and screening rules fixed so later months are genuinely comparable, and would flag any scope change before drawing conclusions from month-to-month differences.

AI recommendation trend

Observed recommendation rate (%), Nov 2026

  • GoodRx Careno change
    Nov 202634.58%

Separate selected monthly samples. Missing points are unavailable, not zero. Provider/prompt equivalence is unverified; rate movement does not demonstrate causation.

/ Take the next step

Want to Understand Your AI Citation Footprint?

We start every engagement with a full audit of how AI systems reference your brand today.

Measurable, Repeatable Programme

Build a durable foundation of credible citations that compounds over time and continues to influence AI answers as new queries emerge

Citation Architecture Review

Identify which high-authority community sources are and aren't working in your favour across AI platforms.

AI Visibility Audit

Understand exactly how LLMs are referencing your brand today and which sources are shaping those answers.

Step 1. Measure

Questions This Section Answers

  • What should the agency measure and verify first for GoodRx Care?

AI answers contained 0 conflicting claims about GoodRx Care: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No conflicting claims about GoodRx Care appeared in the captured answers, so there is nothing urgent to correct. That clean result is reassuring but not a reason to skip verification, since the absence of disputes in one sample does not confirm that every statement about the brand is accurate.

The agency would build a visibility comparison against the leading competitors and a short list of claims worth checking against primary sources. Together these give the client a defensible basis for deciding where to spend effort, separating reputation questions from reach questions.

Step 2. Make the website consistent

Questions This Section Answers

  • Which recorded claim differences about GoodRx Care should be verified before proposed page edits?

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

No disputed topics were supplied for this part of the analysis, so there is no claim to adjudicate here. The agency would not invent one. Instead it would confirm how GoodRx Care is described across its own pages and check that entity names, service descriptions and dates are stated consistently.

Where any apparent conflict later emerges, the first step is to resolve the entity, the date and the source before deciding whether a correction is warranted. Different dates can explain an apparent conflict. Page briefs would only be drafted once approved facts are confirmed, and any proposed edit would rest on current primary-source verification.

Step 3. Align the external narrative

Questions This Section Answers

  • Which cited third-party pages are relevant to fact review for GoodRx Care?

Cited page selected for review

Citation appearances in all captured answers

Answers mentioning the company

Conflicting claims linked to this page

https://walgreens.com/topic/virtual-healthcare/sexual-health/sildenafil.jsp

54

53

0

https://walgreens.com/topic/virtual-healthcare/sexual-health/tadalafil.jsp

30

29

0

https://plushcare.com/viagra-sildenafil-prescription

22

22

0

https://plushcare.com/cialis-tadalafil-prescription

19

19

0

https://sesamecare.com/complaint/erectile-dysfunction

16

15

0

https://sesamecare.com/medication/tadalafil

14

14

0

These pages were selected because they relate to the company in the captured answers. Their current contents still need checking before any correction request. A page linked to a conflicting claim is not necessarily its cause, and the same answer may contribute to more than one row.

The cited pages selected for review are mostly third-party pharmacy and telehealth pages, and none is linked to a conflicting claim about GoodRx Care. Citation does not establish that a page influenced an answer, so these are candidates for reading, not for correction requests.

The agency would review each page's current contents and note whether it describes GoodRx Care accurately and in context. Where a page is relevant and out of date, a polite evidence-backed request may be justified; where it is accurate, the decision is to leave it alone. Publisher control is never assumed.

Step 4. Optimize priority company pages

Questions This Section Answers

  • Which observed GoodRx Care website pages should receive review briefs?

Company website page

Citation appearances in all captured answers

Benchmark answers citing the page

Recommending answers citing the page

https://goodrx.com/sildenafil/viagra-now-available-directly-online

64

64

42

https://goodrx.com/care/services/erectile-dysfunction/sildenafil-online

50

50

45

https://goodrx.com/care/services/erectile-dysfunction

44

43

39

https://goodrx.com/care/services/erectile-dysfunction/tadalafil-online

41

41

33

https://goodrx.com/healthcare-access/telehealth/popular-telehealth-apps

23

3

2

https://goodrx.com/tadalafil-cialis

22

22

15

https://goodrx.com/conditions/erectile-dysfunction/how-to-talk-to-your-doctor-about-erectile-dysfunction-medications

20

20

14

https://goodrx.com/care/services/glp-1-weight-loss

19

0

0

The company's website was cited 511 times across 96 distinct page addresses; the table shows 8 pages selected for review. Zeros in the answer columns mean no matching answers were recorded. A cited page is not automatically a page that accompanied a recommendation.

GoodRx Care's own site is cited widely, and several service pages appear in answers that also recommend the company. That makes the owned pages a sensible place to concentrate brief work, since they already reach the conversation and can be checked against approved facts.

Some cited pages, including the weight-loss service page, appear in answers that do not mention the company at all. Those are worth understanding before any rewrite. The agency would prepare page briefs using approved facts and real audience questions, and would check existing coverage before proposing anything new.

Step 5. Publish around buyer questions

Questions This Section Answers

  • Which observed buyer questions support content briefs for GoodRx Care?

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

What are the best online ED pills?

3

3

3

What is the best online treatment for ED?

3

3

3

Are there any alternatives to Rocket RX?

4

2

2

Can I get an ED prescription online?

2

2

2

What's the best ED medication online?

3

2

2

What's the best online prescription?

3

2

2

Who are the top telehealth providers?

4

2

2

best viagra online

2

2

2

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

The recorded questions cluster around choosing an online ED treatment and getting a prescription online, with a few comparison-style questions about alternatives and top telehealth providers. GoodRx Care appears in most of these answers and is recommended in nearly all of them, which suggests the brand is already competitive on the questions that matter.

The opportunity is to reinforce that position with content that answers the underlying buyer concerns directly. The agency would check existing coverage first, then draft briefs around the questions where the brand appears, rather than assuming any question reflects search demand or a content gap.

Our 90-day action plan

Questions This Section Answers

  • How should the agency sequence the proposed GoodRx Care work and judge completion?

Period

Deliverable

Completion criterion

Days 1–30

Baseline scorecard, scoped fact-review register and page/source shortlist

Each record has an owner, evidence requirement and review status

Days 31–60

Approved page briefs and justified publisher requests

Separate confirmed edits, no-change decisions, requests and responses

Days 61–90

Buyer-content briefs and a fresh scorecard

Record work completed separately from measured answer outcomes and comparability limits

The first month produces a baseline scorecard, a scoped fact-review register and a shortlist of pages and sources, each with an owner and a clear evidence requirement. This gives later work something concrete to build on.

The second month turns approved facts into page briefs and justified publisher requests, with confirmed edits, no-change decisions, requests and responses recorded separately. The third month adds buyer-question content briefs and a fresh scorecard. Completed work is reported separately from measured answer outcomes, and no visibility gain is promised.

Methodology

Questions This Section Answers

  • How are GoodRx Care answer metrics and citation populations defined?

This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 483 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.

An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.

The wider citation analysis covers 800 captured answers and 5650 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.

Monthly sample coverage:

Reporting month

Answers included

AI services covered

Services

Nov 2026

483

6

ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity

July 2026 measured a different set of companies, so it is excluded from this comparison. August 2026 measured a different set of companies, so it is excluded from this comparison. September 2026 measured a different set of companies, so it is excluded from this comparison. Earlier editions (October 2026) used a narrower set of questions. This edition includes all captured answers screened as relevant and establishes a broader baseline. Earlier figures remain in the archive; they are not used to claim a change in performance.

Future editions using the same screening scope can be compared against this baseline.

The answers were captured for a single reporting month, and the exact collection dates have not been verified. Recommendation counts require both an endorsement and positive wording, and placement counts sit inside recommendations rather than adding to them. Because one answer can cover several companies, company totals cannot be summed into distinct answers.

Citation appearances across all captured answers are a different measure from benchmark answers citing a page. The current contents of cited pages and any disputed claims still need independent verification.

Our first three priorities

The first priority is to lock in the baseline. The agency would confirm the question set and screening rules, then build a scorecard that separates reach from placement so future months can be read against a stable reference.

The second is verification. With no conflicting claims recorded, the work is to check how GoodRx Care is described on its own service pages and on the cited third-party pages, resolving entity and date questions before any correction is proposed.

The third is buyer content. The recorded questions about choosing and obtaining ED treatment online are where the brand already appears and is recommended, so briefs there would reinforce a strength rather than chase an unproven gap.

This report supports CiteWorks Studio's examination of how AI search is recommending ED Treatment Pills. For more detail, you can also read ED Treatment Pills: AI Visibility Discovery Index.

/ Learn More

Understanding AI search visibility.

AI search experiences create answers by pulling information from many places online and summarizing it into a single response.

What Is AI Citation Intelligence?
AI citation intelligence is the process of measuring where AI platforms source their information and how frequently a brand is mentioned or referenced in AI-generated responses. Because LLMs synthesize across multiple sources, the sites and brands that appear repeatedly tend to influence how a topic or company is framed. This practice focuses on identifying which sources shape AI outputs and tracking brand visibility across different AI systems.
What Is Citation Architecture?
Citation architecture describes the set of sources that consistently inform how AI systems talk about a brand, product, or topic. LLMs draw from websites, articles, forums, and public discussion, and the sources they rely on most often become the backbone of their answers. Building strong citation architecture means ensuring that accurate, credible, high authority sources are the ones most likely to shape the way AI tools summarize and recommend a brand.
What Is Generative Engine Optimization?
Generative engine optimization (GEO) is the practice of improving the chances that AI systems use and cite your brand or content when generating answers. While traditional SEO is centered on ranking pages in search results, GEO focuses on how LLMs retrieve, interpret, and combine information when responding to a question. The objective is to strengthen the content and sources AI systems rely on, so your brand is treated as a trusted reference in AI responses.
What Is AI Share of Voice?
AI share of voice tracks how often a brand appears in AI-generated answers compared with competitors in the same category. It reflects visibility across AI platforms such as ChatGPT, Gemini, Claude, and Perplexity. Monitoring AI share of voice helps organizations see whether AI systems consistently include and recommend their brand for key queries or whether competitor brands are showing up more often.

About The Author

Mark Huntley

Mark Huntley

Founder and CEO

Mark Huntley, J.D. is founder of CiteWorks Studio, a strategic advisory focused on visibility, authority, and recommendation presence in AI-shaped search environments. His work centers on embedding-level GEO, vector optimization, and cosine gap engineering — helping brands align their digital presence with the retrieval systems that increasingly shape discovery, interpretation, and choice.

VIEW ALL CASE STUDIESREQUEST AN AI VISIBILITY AUDIT